# Coenzyme Q10 Statin Muscle Pain Meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/coenzyme-q10-statin-muscle-pain-meta-analysis-evidence-review
Category: evidence-review
Summary: Coenzyme Q10 Statin Muscle Pain Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pa
Last reviewed: 2026-08-08
Reviewed by: Migaku Evidence Review
# Coenzyme Q10 Statin Muscle Pain Meta-analysis: What the Evidence Says

## Quick Answer

Coenzyme Q10 Statin Muscle Pain Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 systematic review, 1 preclinical study.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Effects of coenzyme Q10 supplementation on myopathy in statin-treated patients: a systematic review and meta-analysis | systematic review | 1 | 2025-01-01 | 10.1017/jns.2025.10043 |
| A to Z of Health: An Evidence-Based Narrative Review of Multivitamin-Multimineral and Nutraceutical Supplementation | preclinical study | 4 | 2026-04-30 | 10.7759/cureus.108032 |

## What The Sources Report

- This isoprenoid is essential for the endogenous synthesis of CoQ10.As CoQ10 is only supplied in small quantities with food and is predominantly synthesised endogenously,statin intake can lead to reduced CoQ10 levels. [Kovacic Svenja (2025); evidence level 1]
- In order to evaluate the potential bias on the individual study level and to summarise the results, the RoB2 online tool was used.Risk of bias assessment was conducted by SK and SH. [Kovacic Svenja (2025); evidence level 1]
- More than two billion people are at risk of micronutrient deficiencies, which often involve multiple, rather than single, nutrients. [Muacevic Alexander (2026); evidence level 4]
- They are widely used to help individuals meet their daily nutrient requirements, support overall health, and address increased nutritional needs associated with pregnancy, aging, and illness. [Muacevic Alexander (2026); evidence level 4]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For coenzyme q10 statin muscle pain meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Kovacic Svenja (2025). Effects of coenzyme Q10 supplementation on myopathy in statin-treated patients: a systematic review and meta-analysis. DOI: 10.1017/jns.2025.10043. PMCID: PMC12554813. PMID: 41158831. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12554813/
- Muacevic Alexander (2026). A to Z of Health: An Evidence-Based Narrative Review of Multivitamin-Multimineral and Nutraceutical Supplementation. DOI: 10.7759/cureus.108032. PMCID: PMC13222036. PMID: 42220661. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13222036/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.